UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 01/2021, Volume 397, Issue 10271, pp. 258 - 259
Drugs | Rheumatology | Rituximab | Lymphocytes T | Arthritis | Kinases | Interleukin 6 | Depletion | Inhibitors | Precision medicine | Lymphocytes B | Biopsy | Tumor necrosis factor | Interleukin 6 receptors | Rheumatoid arthritis | Structural damage | Response rates | Janus kinase | TNF inhibitors | Tumor necrosis factor-TNF | Clinical medicine | Methotrexate | Tumors
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10089, pp. 73 - 84
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Back Pain - etiology | Spondylitis, Ankylosing - diagnosis | Humans | Inflammation - classification | Spondylitis, Ankylosing - classification | Spondylitis, Ankylosing - epidemiology | Magnetic Resonance Imaging - methods | Inflammation - diagnosis | Spondylitis, Ankylosing - physiopathology | Early Diagnosis | Fluocinolone acetonide | Interleukins | Drugs | Pathogenesis | Interleukin | Clinical trials | Arthritis | Damage prevention | Inflammatory diseases | Bone growth | Classification | Tumor necrosis factor-TNF | Nonsteroidal anti-inflammatory drugs | Ankylosing spondylitis | Cytokines | Rheumatic diseases | Inflammation | Patients | Anti-inflammatory agents | Interleukin 17 | Studies | Spondylitis | Magnetic resonance imaging | Tumor necrosis factor | Structural damage | Bone (long) | Histocompatibility antigen HLA | Osteogenesis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of rheumatology, ISSN 0315-162X, 01/2017, Volume 44, Issue 1, pp. 1 - 3
Journal Article
Nature reviews. Rheumatology, ISSN 1759-4790, 05/2016, Volume 12, Issue 5, pp. 282 - 295
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Glucocorticoids - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Spondylarthritis - diagnostic imaging | Spondylarthritis - immunology | Humans | Spondylitis, Ankylosing - drug therapy | Bone Density Conservation Agents - therapeutic use | Antibodies, Monoclonal - therapeutic use | Spondylarthritis - drug therapy | Ustekinumab - therapeutic use | Spondylitis, Ankylosing - diagnostic imaging | Radiography | Spondylitis, Ankylosing - immunology | Magnetic Resonance Imaging | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Abatacept - therapeutic use | Diphosphonates - therapeutic use | Disease Management | C-Reactive Protein - immunology | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antirheumatic Agents - therapeutic use | Care and treatment | Antirheumatic agents | C-reactive protein | Tumor necrosis factor | Spondyloarthropathies | Development and progression | Arthritis | Dosage and administration | Research | Health aspects | Index Medicus
Journal Article
Expert opinion on biological therapy, ISSN 1471-2598, 07/2019, Volume 19, Issue 7, pp. 631 - 641
ixekizumab | netakimab | interleukin 17 | secukinumab | axial spondyloarthritis | bimekizumab | Ankylosing spondylitis | brodalumab | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Antibodies, Monoclonal, Humanized - therapeutic use | Humans | Spondylitis, Ankylosing - drug therapy | Interleukin-17 - immunology | Antibodies, Monoclonal - therapeutic use | Spondylarthritis - drug therapy | Spondylarthritis - pathology | Clinical Trials as Topic | Spondylarthritis - metabolism | Spondylitis, Ankylosing - metabolism | Spondylitis, Ankylosing - pathology | Index Medicus
Journal Article
Best practice & research. Clinical rheumatology, ISSN 1521-6942, 06/2018, Volume 32, Issue 3, pp. 472 - 484
Treatment | Spondyloarthritis | Ankylosing spondylitis | Psoriatic arthritis | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Care and treatment | Psoriasis | Interleukins | Tofacitinib | Therapeutics | Monoclonal antibodies | Arthritis | T cells | Epidemiology | Homeopathy | Materia medica and therapeutics
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 05/2014, Volume 73, Issue 5, pp. 817 - 823
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Time Factors | Humans | Immunosuppressive Agents - therapeutic use | Spondylitis, Ankylosing - drug therapy | Ustekinumab | Adult | Female | Male | Treatment Outcome | Spondylitis, Ankylosing - pathology | Treatment outcome | Drug therapy | Analysis | Ankylosing spondylitis | Psoriasis | Cytokines | Arthritis | Inflammation | Patients | Crohns disease | Quality of life | Studies | Proteins | Bone marrow | Tumor necrosis factor-TNF | Pharmaceutical industry | Drug dosages | Index Medicus
Journal Article
Nature reviews. Rheumatology, ISSN 1759-4790, 12/2019, Volume 15, Issue 12, pp. 747 - 757
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Biological Factors - therapeutic use | Interleukin-17 - metabolism | Immunotherapy - methods | Interleukin-23 - metabolism | Interleukin-17 - antagonists & inhibitors | Interleukin-23 - antagonists & inhibitors | Spondylarthritis - immunology | Humans | Immunosuppressive Agents - therapeutic use | Spondylarthritis - therapy | Spondylarthritis - metabolism | Antirheumatic Agents - therapeutic use | Animal models | Psoriasis | Pathogenesis | Therapeutic applications | Rheumatic diseases | Clinical trials | Interleukin 23 | Lymphocytes T | Arthritis | Bone (subchondral) | Interleukin 17 | p40 Protein | Inflammatory diseases | Spondylitis | Bone growth | Tumor necrosis factor | p19 Protein | Monoclonal antibodies | Bone marrow | Sacroiliitis | Osteogenesis | Ankylosing spondylitis | Index Medicus
Journal Article